July 14, 2026

Setmelanotide in Patients With Acquired Hypothalamic Obesity From Brain Tumors

Setmelanotide significantly reduced body mass index (BMI) and signs of hunger in patients with acquired hypothalamic obesity, according to findings from the phase III TRANSCEND trial published in The ...

The ASCO Post

July 06, 2026

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.

MDSpire News

July 01, 2026

Breast Cancer: Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease

The U.S. Food and Drug Administration (FDA) has approved palbociclib (Ibrance) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult...

The ASCO Post

July 01, 2026

Breast Cancer: Palbociclib-Based Regimen Approved for HR-Positive, HER2-Positive Metastatic Disease

The U.S. Food and Drug Administration (FDA) has approved palbociclib (Ibrance) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adult...

The ASCO Post

June 29, 2026

Fertility Preservation Access Remains ‘Limited and Unequal’ for Many Girls and Young Women With Cancer

A review of existing literature from 2006 to 2025 revealed inconsistent implementation of fertility preservation guidelines, resulting in inequities across gender, race, geography, and socioeconomic s...

The ASCO Post

June 29, 2026

Fertility Preservation Access Remains ‘Limited and Unequal’ for Many Girls and Young Women With Cancer

A review of existing literature from 2006 to 2025 revealed inconsistent implementation of fertility preservation guidelines, resulting in inequities across gender, race, geography, and socioeconomic s...

The ASCO Post

June 22, 2026

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia

In a long-term individual patient-level pooled analysis reported in the Journal of Clinical Oncology, Gandini et al found that low-dose tamoxifen was associated with good outcomes in patients with non...

The ASCO Post

June 22, 2026

Low-Dose Tamoxifen in Noninvasive Breast Neoplasia

In a long-term individual patient-level pooled analysis reported in the Journal of Clinical Oncology, Gandini et al found that low-dose tamoxifen was associated with good outcomes in patients with non...

The ASCO Post

June 18, 2026

FDA Warns of Ongoing Breast Biopsy Needle Shortage

The U.S. Food and Drug Administration (FDA) issued notice of supply chain interruptions for stereotactic breast biopsy needles due to recent supplier issues. The agency noted that the duration of the ...

The ASCO Post

June 16, 2026

Thyroid Cancer: Reproductive Lifespan, Hormone Therapy Potentially Linked to Incidence

Longer exposure to hormone replacement therapy and longer reproductive lifespan showed potential associations with increased thyroid cancer risk in women​​​​​​​, according to findings presented at END...

The ASCO Post